The technology behind the method

Non-invasive measurement of gases

The technology is based on gas in scattering media absorption spectroscopy (GASMAS), developed by scientists at the division of Atomic Physics, Lund University.

This method allows non-invasive measurement of gases inside body cavities, including the lungs and sinuses. Gas, such as oxygen and water vapor absorb light of very distinct wavelengths, unlike the broader absorption by the surrounding tissue which enables the gas concentration to be measured non-invasively.

With the foundation in gas spectroscopy with weak diode laser light GPX Medical can provide safe diagnostics to monitor the lungs of preterm born babies and help diagnose sinusitis.

For Investors

GPX Medical is on a journey to create better care for for our most vulnerable patients.

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to Gasporox AB (publ) with the aim to develop and commercialize medical applications of the GASMAS technology. The company is owned by Gasporox AB (publ) to 53,3%, by Norsk Elektro Optikk AS to 36,2% and by the team to 10,5%. The company is located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB
Tellusgatan 13
224 57 Lund